Dr. Mohammed Ali Al-Zoubaidi, MD

Dr. Al-Zoubaidi practices at Mount Vernon Dialysis in Mount Vernon, Illinois.

Dr. Al-Zoubaidi's NPI, 1063606432, was assigned on August 29, 2007. Dr. Al-Zoubaidi graduated from Royal College of Surgeons Ireland in 2004. Dr. Al-Zoubaidi holds Illinois license 036137242.

Dr. Al-Zoubaidi's primary practice is Mount Vernon Dialysis, at 416 N 12th St, Mount Vernon, IL 62864 in Jefferson County. The practice phone is (618) 244-3407.

Dr. Al-Zoubaidi's primary practice is Mount Vernon Dialysis in Mount Vernon, Illinois. Dr. Al-Zoubaidi is also affiliated with SSM Health Good Samaritan Hospital - Mt. Vernon. The medical group on file is Al-Zoubaidi Vein & Vascular Center of Southern Illinois. Dmand AI also links Dr. Al-Zoubaidi to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Zoubaidi practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Al-Zoubaidi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Al-Zoubaidi is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Al-Zoubaidi's licenses on file in 6 states: Illinois, Arizona, California, Florida, Missouri and Texas.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Al-Zoubaidi treats.

CMS data shows 1,214 Medicare services from Dr. Al-Zoubaidi across 8 procedure codes in 2024, for 127 Medicare patients. Medicare paid $6,147 for them.

CMS counts 127 Medicare patients who saw Dr. Al-Zoubaidi in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Zoubaidi's median patient age at 69, with 57% women.

In 2024, Dr. Al-Zoubaidi wrote 81 Medicare Part D claims for 39 patients. 89% of them were for generic drugs. CMS names the drug for 58 of them, across 1 drug with 11 or more claims each, at $581 in total drug cost. In 2023, CMS named 79 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Al-Zoubaidi for performance year 2024, reported through an alternative payment model (APM). Dr. Al-Zoubaidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of leg revascularization (restoring blood flow) by Dr. Al-Zoubaidi, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 164 general payments to Dr. Al-Zoubaidi from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Endologix, Inc. paid the most, $4,785.

Dmand AI lists 1 award for Dr. Al-Zoubaidi.

Dr. Al-Zoubaidi graduated from Royal College of Surgeons Ireland in 2004. Dr. Al-Zoubaidi is a member of ACS.

Dr. Al-Zoubaidi is in network with 14 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.